You are here

Article Text

Article menu

other Versions

Download PDFPDF
PostScript
Letter
Use of donor breast milk in neonatal units in the UK
  1. Christos S Zipitis1,2,
  2. Jonathan Ward2,
  3. Rohini Bajaj2
  1. 1Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
  2. 2Neonatal Unit, Wrightington Wigan & Leigh NHS Foundation Trust, Wigan, UK
  1. Correspondence to Dr Christos S Zipitis, Neonatal Unit, Royal Albert Edward Infirmary, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan Lane, Wigan, WN1 2NN, UK

https://doi.org/10.1136/archdischild-2014-307606

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Maternal breast milk is the best source of enteral nutrition for preterm or low birthweight infants. With insufficient volumes of maternal breast milk, donor-expressed breast milk (DEBM) or artificial formula are two common alternatives. Despite publication of a recently updated Cochrane review1 demonstrating a decrease in the risk of necrotising enterocolitis (NEC) in babies receiving DEBM compared with those receiving formula, concerns about the methodological quality of some of the included studies, their applicability to current neonatal practices (the majority of included trials were carried out in the 70 s and 80 s), the slower in-hospital growth rates of those on DEBM and the fact that growth-restricted premature infants as well as unwell infants were generally excluded …

    View Full Text

    Footnotes

    • Contributors We confirm that all listed authors fulfil the criteria for authorship. Further, we confirm that no other person who fulfils these criteria has been excluded.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.